A WOMAN WITH 5 CONSECUTIVE FETAL DEATHS - CASE-REPORT AND RETROSPECTIVE ANALYSIS OF HYPERHOMOCYSTEINEMIA PREVALENCE IN 100 CONSECUTIVE WOMEN WITH RECURRENT MISCARRIAGES
I. Quere et al., A WOMAN WITH 5 CONSECUTIVE FETAL DEATHS - CASE-REPORT AND RETROSPECTIVE ANALYSIS OF HYPERHOMOCYSTEINEMIA PREVALENCE IN 100 CONSECUTIVE WOMEN WITH RECURRENT MISCARRIAGES, Fertility and sterility, 69(1), 1998, pp. 152-154
Objective: To evaluate the medical relevance of hyperhomocysteinemia i
n women with primary recurrent miscarriages. Design: Case report and r
etrospective cross-sectional study. Setting: Hematology outpatient dep
artment of a university hospital. Patient(s): Case report concerning a
woman with five consecutive fetal losses. One hundred consecutive wom
en with primary recurrent unexplained miscarriages (study group) and m
atched healthy controls (control group) with no antecedent fetal loss.
Intervention(s): Venous blood sample collection in resting individual
s. Main Outcome Measure(s): Plasma total homocysteine concentrations,
plasma folate concentrations, and DNA analysis for the C677T mutation
of the 5,10 methylene tetrahydrofolate reductase gene. Normal threshol
d homocysteine concentration was obtained from values found in the con
trol group (95th percentile). Result(s): The case patient was hyperhom
ocysteinemic, was homozygous for the C677T mutation in the methylene t
etrahydrofolate reductase gene, and had plasma folate deficiency. Foli
c acid and pyridoxine administration normalized the homocysteine conce
ntration and favored a successful pregnancy. In the retrospective stud
y, 12 of 100 patients were hyperhomocysteinemic. Twenty percent had th
e C677T methylene tetrahydrofolate reductase genotype and 15% had low
plasma folate concentrations. The highest values of homocysteine conce
ntration were found in patients with both the C677T genotype and folat
e deficiency, Conclusion(s): Hyperhomocysteinemia should be identified
in women with recurrent miscarriages because therapeutic normalizatio
n might permit a normal birth. ((C) 1998 by American Society for Repro
ductive Medicine.).